Do Not Treat This Asymptomatic Bacteriuria
In this 65-year-old woman with Group B Streptococcus (GBS) at 10,000-25,000 CFU/mL in urine but no urinary symptoms, you should NOT treat with antibiotics. This represents asymptomatic bacteriuria (ASB), and treatment provides no benefit while causing harm through adverse effects, costs, and antimicrobial resistance 1.
Why No Treatment is Indicated
The 2019 IDSA guideline on asymptomatic bacteriuria provides a strong recommendation against screening for or treating ASB in healthy postmenopausal women (which applies to your 65-year-old patient) 1. This recommendation is based on:
- Moderate-quality evidence showing no benefit from treatment
- High-quality evidence of harm from antibiotics including adverse effects, increased costs, and antimicrobial resistance
- No evidence that treating ASB prevents symptomatic UTI, pyelonephritis, renal scarring, or renal insufficiency 1
The guideline explicitly states that while symptomatic UTI occurs more frequently in women with bacteriuria than nonbacteriuric women, observational studies show no differences in rates of hypertension, chronic kidney disease, serum creatinine levels, or mortality between women with or without bacteriuria 1.
Understanding the Low Colony Count
The colony count of 10,000-25,000 CFU/mL is particularly important here:
- This is below the traditional threshold of ≥100,000 CFU/mL typically used to define significant bacteriuria
- Recent research shows GBS growth in urine is significantly more associated with high-grade ABU (≥10⁴ CFU/mL) than with acute UTI 2
- Even when GBS is present at higher counts (≥10⁵ CFU/mL), one-third of patients with voided urine showing these counts had only contaminated urine with no true bacteriuria when suprapubic aspiration was performed 3
Key Clinical Pitfalls to Avoid
Do not be misled by the lab comment about penicillin being the drug of choice. This statement refers to treatment of symptomatic beta-hemolytic streptococcal infections, not asymptomatic bacteriuria. The lab is providing susceptibility guidance for when treatment is indicated—which it is not in this case.
Do not confuse this with pregnancy management. In pregnant women, GBS bacteriuria at any colony count warrants intrapartum antibiotic prophylaxis 4, but your patient is a 65-year-old non-pregnant woman where different guidelines apply.
When Treatment WOULD Be Indicated
Treatment would be appropriate only if:
- The patient develops acute urinary symptoms (dysuria, frequency, urgency, suprapubic pain)
- Fever or systemic signs suggesting pyelonephritis or invasive infection develop
- The patient were pregnant (requiring intrapartum prophylaxis regardless of symptoms) 4
- The patient were undergoing urologic procedures where mucosal bleeding is anticipated
The Evidence Against Treatment
The 2019 IDSA guideline reviewed multiple trials showing that antimicrobial treatment of ASB in schoolgirls and women:
- Did not reduce symptomatic UTI rates at 4-year follow-up 1
- Did not prevent renal scarring 1
- In one study, paradoxically led to 6 cases of acute pyelonephritis and 1 case of cystitis within 5 months following penicillin treatment for another indication 1
The 2024 WikiGuidelines consensus reinforces that asymptomatic bacteriuria is prevalent in older adults, particularly institutionalized individuals, with treatment showing no benefit over placebo 5. They emphasize that overtesting and overtreatment with antibiotics for nonsymptomatic cases remains inappropriately high.
Your Action Plan
- Document that this represents asymptomatic bacteriuria with no treatment indicated
- Educate the patient that bacteria in urine without symptoms does not require antibiotics
- Monitor clinically—if urinary symptoms develop, reassess and consider treatment at that time
- Do not repeat urine cultures unless symptoms develop